DHA is the omega-3 that builds BRAINS — literally. It makes up 40% of all polyunsaturated fatty acids in the brain and 60% of the fatty acids in the retina. Our research shows DHA is not just another omega-3: it has distinct functions from EPA. EPA is primarily anti-inflammatory, but DHA is structural — it's physically incorporated into neuronal membrane phospholipids, modulating membrane fluidity, receptor function, and synaptic signaling. For brain development (pregnancy, infancy), DHA supplementation has STRONG evidence. For depression, EPA appears more important than DHA. The two serve different biological roles despite being lumped together as "fish oil."
DHA is incorporated into membrane phospholipids (primarily phosphatidylethanolamine and phosphatidylserine) of neurons and photoreceptors. Its 22-carbon, 6-double-bond structure creates unique membrane properties: (1) membrane fluidity — DHA's highly unsaturated chains keep membranes fluid, enabling rapid receptor conformational changes (essential for neurotransmission and rhodopsin function in vision); (2) lipid raft organization — DHA modulates cholesterol-rich microdomains critical for signal transduction; (3) neuroprotectin D1 (NPD1) synthesis — DHA is enzymatically converted to NPD1, a specialized pro-resolving mediator that protects neurons from oxidative damage and apoptosis; (4) BDNF expression — DHA upregulates brain-derived neurotrophic factor; (5) anti-inflammatory via resolvin D series production.
Based on independent third-party laboratory analysis
Category pass rate: ~90% of fish oil products passed content testing. Rancidity is the primary failure mode — ~10% of products are already oxidized before opening.
Contamination risk: MODERATE. All tested products passed heavy metal testing. Mercury, lead, cadmium all below detection limits. Fish oil purification processes (molecular distillation) effectively remove contaminants.
Reviewed by the Scan Dose Research Team and Clinical Advisory Board | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.
Safety
Dangerous interactions. Talk to your prescriber before using this supplement if you take any of these.
Warfarin (Coumadin)
Omega-3 inhibits platelet aggregation, producing an additive anticoagulant effect on top of warfarin.
Source: PMID: 25062404
Clopidogrel (Plavix)
Dual antiplatelet effect.
Source: FDA label
High-dose Aspirin
Additive antiplatelet effect.
Source: Clinical consensus
Moderate interactions. Monitoring, timing separation, or dose adjustment may be required.
Blood pressure medications
Omega-3 may lower BP modestly.
Source: Clinical consensus
Orlistat (Alli)
Reduces fat absorption, including omega-3.
Source: FDA label
Stop 2 weeks before surgery
Bleeding risk from antiplatelet effect.
Educational information only. This is not medical advice. These statements have not been evaluated by the FDA. Talk to your prescriber before starting, stopping, or combining any supplement with prescription medication.